Beijing biopharmaceutical industry will reach 100 billion yuan

Source: on September 9, 2016, www.chinapharma.com, Beijing held the three phase kick-off meeting of "G20 project" and "scientific and technological research and management of ten major diseases" As one of a series of publicity activities of Beijing Science and Technology Innovation Conference, "G20 project" and "scientific research and management of top ten diseases" are important work arrangements for Beijing to promote the development of biomedicine and medical health science and technology According to the third phase implementation plan, during the 13th Five Year Plan period, Beijing's biomedical industry will reach 180 billion yuan, cultivate more than 10 innovation leading enterprises that have reached the international advanced level, promote more than 100 new varieties of innovative drugs and innovative medical devices with independent intellectual property rights to apply for or carry out clinical trials, and promote 1-2 Major national infrastructure construction projects in the field of life sciences were launched in Beijing The third phase goal of "scientific and technological research and management of ten major diseases" is to form more than 20 innovative achievements with international influence by 2020, formulate 100 technical specifications and standards for diagnosis and treatment, and form 40 advantageous specialties in the leading position in China Yan Aoshuang, director of Beijing Municipal Science and Technology Commission, pointed out that on September 1, the executive meeting of the State Council deliberated and approved the overall plan for strengthening the construction of national science and technology innovation center in Beijing On September 6, the Beijing Municipal Party committee and the Beijing municipal government solemnly held the Beijing Science and Technology Innovation Conference, which is the understanding and deepening of Beijing's own mission and responsibility under the new historical conditions, as well as the mobilization and deployment of the municipal Party committee and the Beijing municipal government to strengthen the construction of the national science and technology innovation center Recently, the central government held the national health and health conference, deliberated and passed the outline of "healthy China 2030", defined the strategic position of giving priority to the development of people's health, and put forward the requirements of promoting health science and technology innovation Beijing Pharmaceutical Science and technology circle will usher in unprecedented major development opportunities It is understood that "G20 project" and "top ten disease science and technology research and management work" were launched in 2010 respectively Up to now, the first two phases of work have been completed, contributing to promoting the leapfrog development of Beijing's biomedical industry, significantly improving the level of medical research, and significantly improving the health level of citizens in the capital During the 12th Five Year Plan period, the biomedical industry has become a new 100 billion level industry in Beijing, with more than 300 clinical approval documents for new drugs, ranking first in China; The awareness rate of the citizens of the capital on the health knowledge of the top ten diseases has increased to more than 80%, more than 300 new technologies and methods have been developed, 136 technical specifications and standards for diagnosis and treatment have been formulated, 55 of which have risen to the national industrial standards, guidelines and specifications.